CAMMX Performance — Cambiar SMID Fund, Investor Class
Data updated: 2026-09-28
CAMMX returned +17.85% year to date and +20.37% over one year to Jul 2026. Annualised returns are +6.25% over 3 years and +4.66% over 5 years. The fund trailed its US Mid-Cap Value category average: $100 invested three years ago grew to $120, against $145 for the category, and to $120 over one year, against $120. Volatility over the past three years was 14.62% a year. In the 12 months to Jul 2026 the fund lost a net $28.9M, and assets reached $39.09M.
CAMMX Growth of $100
What $100 invested in Cambiar SMID Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Mid-Cap Value category average over the same months.
| Period | CAMMX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $120 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $120 | $145 |
| 5 years (Aug 2021 – Jul 2026) | $126 | $156 |
| Since data start (Aug 2019 – Jul 2026) | $180 | $212 |
CAMMX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +17.85% |
| 1 year | +20.37% |
| 3 years (annualised) | +6.25% |
| 5 years (annualised) | +4.66% |
CAMMX Annual Returns
Calendar-year total returns of Cambiar SMID Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +17.86% |
| 2025 | +2.15% |
| 2024 | +5.95% |
| 2023 | +1.88% |
| 2022 | −4.65% |
| 2021 | +38.14% |
| 2020 | +5.45% |
| 2019 (Aug–Dec) | −0.31% |
CAMMX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.0% | +8.5% | −5.5% | +4.1% | +0.7% | +2.4% | +3.0% | — | — | — | — | — |
| 2025 | +5.2% | −5.3% | −2.5% | −2.2% | −0.4% | +2.3% | +3.4% | −1.9% | −3.5% | +4.2% | +3.8% | −0.4% |
| 2024 | +7.8% | −7.7% | +2.9% | +4.5% | +5.8% | −1.3% | +1.3% | −2.8% | +0.9% | +0.7% | +2.9% | −7.9% |
| 2023 | +6.2% | +1.3% | −2.4% | −1.3% | +2.6% | +7.0% | −4.8% | −4.3% | −4.0% | −2.4% | −1.7% | +6.7% |
| 2022 | −4.0% | −5.5% | 0.0% | +0.9% | +7.2% | −5.6% | +1.5% | +11.1% | −7.8% | −5.3% | +7.4% | −2.8% |
| 2021 | +15.2% | +4.7% | +4.7% | +8.2% | −0.3% | −1.4% | +1.4% | +3.5% | −6.1% | +1.1% | −4.5% | +8.1% |
| 2020 | +4.9% | +11.6% | −20.7% | −10.5% | +4.6% | +0.9% | +7.8% | +1.2% | −0.7% | +3.3% | +2.4% | +5.1% |
| 2019 | — | — | — | — | — | — | — | +1.1% | +4.2% | −4.0% | −3.1% | +1.7% |
CAMMX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 14.62%
- 3-year Sharpe ratio: 0.12 (vs 4.5% risk-free rate)
- Best month: +8.54% (Feb 2026)
- Worst month: −7.93% (Dec 2024)
CAMMX Fund Flows
Monthly money in and out of Cambiar SMID Fund, from SEC Form N-PORT.
- 12-month net flow: −$28.9M
- 12-month gross sales (incl. reinvestments): $24.0M
- Sales ÷ redemptions: 0.45×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $125K | $3.9M | −$3.8M |
| Jun 2026 | $168K | $4.7M | −$4.6M |
| May 2026 | $780K | $1.1M | −$336K |
| Apr 2026 | $265K | $2.0M | −$1.7M |
| Mar 2026 | $289K | $2.7M | −$2.5M |
| Feb 2026 | $659K | $1.8M | −$1.2M |
| Jan 2026 | $333K | $3.2M | −$2.9M |
| Dec 2025 | $18.7M | $11.8M | $6.9M |
| Nov 2025 | $1.3M | $3.1M | −$1.8M |
| Oct 2025 | $438K | $12.2M | −$11.8M |
| Sep 2025 | $324K | $3.0M | −$2.7M |
| Aug 2025 | $571K | $3.1M | −$2.5M |
CAMMX Assets Under Management
Net assets of Cambiar SMID Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $39.09M |
| 2026-04-30 | $45.31M |
| 2026-01-31 | $47.69M |
| 2025-10-31 | $55.46M |
| 2025-07-31 | $72.65M |
| 2025-04-30 | $85.94M |
| 2025-01-31 | $106.49M |
| 2024-10-31 | $162.17M |
| 2024-07-31 | $173.05M |
| 2024-04-30 | $179.86M |
| 2024-01-31 | $182.99M |
| 2023-10-31 | $167.67M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.